CVS Health Corporation (CVS) Valuation — DCF & Advanced Analysis | MarketCI

Navigation

Explore Analysis Investor Relations AI Assistant Compare Screener

Help Pricing Privacy Terms

Navigation

Explore Analysis Investor Relations AI Assistant Compare Screener

Help Pricing Privacy Terms

CVS Health Corporation (CVS) Valuation — DCF & Advanced Analysis | MarketCI | MarketCI

CVS

Market Closed

CVS Health Corporation

NYSEHealthcare Medical - Healthcare Plans

300.00K employees

CEO: J. David Joyner

Founded: 1996

$98.32

+$0.00(+NaN%)

Market Cap

125.45B

Beta

0.62

52W Range

N/A

Dividend Yield

2.71%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

Comprehensive Valuation

In-depth valuation analysis including DCF scenarios and peer comparisons.

AI Insight: CVS Health appears significantly undervalued, with a current price at $100.68 versus a PERT-weighted fair value of $207.35 and a high-confidence upside of 105.9%. Monte Carlo analysis indicates zero downside below the current price, but extreme volatility (106.64% coefficient of variation) signals elevated risk. Financial health scores reveal poor profitability and growth, implying fundamental challenges amid valuation optimism.

Enhanced Football Field Analysis

Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore CVS

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples